Inspire Investing LLC Grows Stock Position in Chemed Co. (NYSE:CHE)

Inspire Investing LLC boosted its holdings in Chemed Co. (NYSE:CHE) by 5.6% in the 3rd quarter, HoldingsChannel reports. The fund owned 5,409 shares of the company’s stock after acquiring an additional 288 shares during the quarter. Inspire Investing LLC’s holdings in Chemed were worth $3,251,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of CHE. Thrivent Financial for Lutherans raised its position in Chemed by 300.3% in the second quarter. Thrivent Financial for Lutherans now owns 116,572 shares of the company’s stock worth $63,249,000 after acquiring an additional 87,449 shares in the last quarter. Impax Asset Management Group plc increased its position in shares of Chemed by 19.5% in the second quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock valued at $172,510,000 after buying an additional 51,974 shares in the last quarter. ProShare Advisors LLC increased its position in shares of Chemed by 6,288.9% in the first quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock valued at $32,482,000 after buying an additional 49,808 shares in the last quarter. TD Asset Management Inc increased its position in shares of Chemed by 23.9% in the first quarter. TD Asset Management Inc now owns 254,953 shares of the company’s stock valued at $163,662,000 after buying an additional 49,176 shares in the last quarter. Finally, Los Angeles Capital Management LLC purchased a new position in shares of Chemed in the first quarter valued at $26,776,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Stock Down 0.0 %

Shares of CHE stock opened at $589.88 on Friday. Chemed Co. has a fifty-two week low of $497.36 and a fifty-two week high of $654.62. The stock has a market cap of $8.93 billion, a P/E ratio of 31.75, a P/E/G ratio of 2.44 and a beta of 0.44. The business has a fifty day simple moving average of $580.69 and a 200-day simple moving average of $572.03.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). Chemed had a net margin of 12.88% and a return on equity of 29.21%. The firm had revenue of $595.88 million during the quarter, compared to analysts’ expectations of $599.20 million. During the same quarter in the prior year, the business earned $4.71 EPS. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. On average, sell-side analysts anticipate that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were paid a dividend of $0.50 per share. The ex-dividend date was Monday, August 12th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. This is a positive change from Chemed’s previous quarterly dividend of $0.40. Chemed’s dividend payout ratio (DPR) is presently 10.76%.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Monday, August 5th. The stock was sold at an average price of $569.63, for a total transaction of $1,139,260.00. Following the sale, the chief executive officer now owns 105,735 shares of the company’s stock, valued at $60,229,828.05. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $569.63, for a total value of $1,139,260.00. Following the sale, the chief executive officer now directly owns 105,735 shares of the company’s stock, valued at approximately $60,229,828.05. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director George J. Walsh III sold 400 shares of the firm’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the sale, the director now directly owns 3,046 shares in the company, valued at approximately $1,819,893.62. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 9,144 shares of company stock valued at $5,264,839 over the last quarter. Insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.